11/27/2023 | 29372100000 | Dissolution Performance Verification Standard - Prednisone 30 tablets /53- | UNITED STATES PHARMACOPEIAL C | 0 | NA | 327.69 | USA | N/A |
11/14/2023 | 29372100000 | Dissolution Performance Verification Standard - Prednisone 30 tablets /53-03-2 | UNITED STATES PHARMACOPEIAL C | 0 | NA | 663.12 | USA | N/A |
10/20/2023 | 29372100000 | DISSOLUTION PERFORMANCE VERIFICATION STANDARD - PREDNISONE 30 TABLETS /53- | UNITED STATES PHARMACOPEIAL C | 0 | NA | 592.92 | USA | N/A |
10/7/2023 | 29372100000 | Dissolution Performance Verification Standard - Prednisone 30 tablets /53-03-2 Prednisone /F161Y0 1222818 | UNITED STATES PHARMACOPEIAL C | 0 | NA | 330.9 | USA | N/A |
10/6/2023 | 29372100000 | 2 DISSOLUTION PERFORMANCE VERIFICATION STANDARD PREDNISONE TABLETS (DISSOLUTION 30 | UNITED STATES PHARMACOPEIAL CONVENT | 0 | NA | 682.46 | USA | N/A |
10/6/2023 | 29372100000 | 2 BXS REFERENCE STANDARD FOR LABORATORY USE, Dissolution Performance Verification Standard -Prednisone (30 tablets) PER BOX, 10.567GM | UNITED STATES PHARMACOPEIAL C | 0 | NA | 627.06 | USA | N/A |
10/4/2023 | 29372100000 | "USP" Dissolution Performance Verification Standard - Prednisone 30 tablets /53-03-2 Prednisone/F161y0 | UNITED STATES PHARMACOPEIAL C | 0 | NA | 884.89 | USA | N/A |
9/21/2023 | 29372100000 | "USP" DISSOLUTION PERFORMANCE VERIFICATION STANDARD - PREDNISONE 30 TABLETS /53- | UNITED STATES PHARMACOPEIAL C | 0 | NA | 2371.07 | USA | N/A |
9/14/2023 | 29372100000 | "USPC" Dissolution Performance Verification Standard - Prednisone 30 tablets /53- | UNITED STATES PHARMACOPEIAL C | 0 | NA | 4530.24 | USA | N/A |
8/30/2023 | 29372100000 | "USP" Dissolution Performance Verification Standard - Prednisone 30 tablets /53-03-2 prednisone | UNITED STATES PHARMACOPEIAL C | 0 | NA | 888.93 | USA | N/A |